503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
86.40%
Net income growth above 1.5x ZETA's 40.68%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-4.80%
Both reduce yoy D&A, with ZETA at -1.61%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
1295.65%
Well above ZETA's 53.19% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
9.48%
SBC growth well above ZETA's 10.68%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-183.70%
Negative yoy working capital usage while ZETA is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-201.49%
Both yoy AR lines negative, with ZETA at -367.30%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
179.26%
Growth well above ZETA's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-754.77%
Both negative yoy, with ZETA at -192.80%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-18.63%
Negative yoy CFO while ZETA is 20.83%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
13.56%
CapEx growth well above ZETA's 14.14%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-61.54%
Both yoy lines negative, with ZETA at -26.79%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
59.13%
Purchases growth of 59.13% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-46.16%
We reduce yoy sales while ZETA is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
92.33%
We have mild expansions while ZETA is negative at -18.84%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-27.34%
We cut debt repayment yoy while ZETA is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-61.29%
Negative yoy issuance while ZETA is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-151.10%
Both yoy lines negative, with ZETA at -23.83%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.